November marks five years since the UK rescheduled Cannabis-Based Products for Medicinal Use (CBPMs). While cannabis is now being prescribed for medical use, exponential growth will require the industry to come together and implement a more coordinated strategy.
That is the reason we are today launching the Medical Cannabis Journal. The journal will give industry leaders a voice – to educate, provide a rallying point, and seed the necessary debates the sector must have to support sustainable growth.
Starting the conversation is Dr Elisabeth Philipps, a clinical neuroscientist and integrative medicine practitioner. In our first article, she argues that a cannabis-based prescription medicines register is a vital step towards greater medical use of cannabis.
Dr Philipps will be joined by other leading voices in the industry – including many of the experts among our membership and wider network. If you would like to contribute an article or discuss an idea for a piece please contact the journal.